Xiu-qing XUE, Cheng-hai SU. Progress of 99Tc-methylenediphosphonate in clinical applications[J]. Int J Radiat Med Nucl Med, 2010, 34(5): 285-288. DOI: 10.3760/cma.j.issn.1673-4114.2010.05.008
Citation: Xiu-qing XUE, Cheng-hai SU. Progress of 99Tc-methylenediphosphonate in clinical applications[J]. Int J Radiat Med Nucl Med, 2010, 34(5): 285-288. DOI: 10.3760/cma.j.issn.1673-4114.2010.05.008

Progress of 99Tc-methylenediphosphonate in clinical applications

  • The main ingredient of 99Tc-methylenediphosphonate(99Tc-MDP) is chelates which formed by the technetium 99Tc after stannous reduction and methylenediphosphonate.Studies have shown that 99Tc-MDP can inhibit the inflammatory response, play anti-inflammatory, anti-rheumatic effect, it also have significant analgesic effect by inhibit prostaglandin synthesis.In addition, 99Tc-MDP also can regulate the body's own immune and bone metabolism to treat the corresponding diseases.Treating rheumatoid arthritis, ankylosing spondylitis, Graves'ophthalmopathy and other autoimmune diseases.Italso has a good effect on pain which is caused by cancer, femoral head necrosis and osteoporosis.Review progress of 99Tc-MDP in clinical applications.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return